SARS-CoV-2 infects cells through angiotensin-converting enzyme 2 (ACE2), a ubiquitous receptor that interacts with the virus’ surface S glycoprotein. Recent reports show that the virus affects the central nervous system (CNS) with symptoms and complications that include dizziness, altered consciousness, encephalitis, and even stroke. These can immerge as indirect immune effects due to increased cytokine production or via direct viral entry into brain tissue. The latter is possible through neuronal access via the olfactory bulb, hematogenous access through immune cells or directly across the blood-brain barrier (BBB), and through the brain’s circumventricular organs characterized by their extensive and highly permeable capillaries. Last, the COVID-19 pandemic increases stress, depression, and anxiety within infected individuals, those in isolation, and high-risk populations like children, the elderly, and health workers. This review surveys the recent updates of CNS manifestations post SARS-CoV-2 infection along with possible mechanisms that lead to them.
Al SaieghFGhoshRLeiboldAAveryMBSchmidtRFTheofanisT others. 2020. Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke. J Neurol Neurosurg Psychiatry91(8):846–8.
2.
AlgahtaniHSubahiAShirahB. 2016. Neurological complications of Middle East respiratory syndrome coronavirus: a report of two cases and review of the literature. Case Rep Neurol Med2016:3502683.
3.
AlmeidaLFToftengSSMadsenKJensenBL. 2020. Role of the renin-angiotensin system in kidney development and programming of adult blood pressure. Clin Sci (Lond)134(6):641–56.
4.
ArbourNDayRNewcombeJTalbotPJ. 2000. Neuroinvasion by human respiratory coronaviruses. J Virol74(19):8913–21.
5.
AvulaANalleballeKNarulaNSapozhnikovSDanduVToomS others. 2020. COVID-19 presenting as stroke. Brain Behav Immun87:115–9.
6.
BaigAMKhaleeqAAliUSyedaH. 2020. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci11(7):995–8.
7.
BiswasIKhanGA. 2020. Coagulation disorders in COVID-19: role of toll-like receptors. J Inflamm Res13:823–8.
8.
BiswasISinghBSharmaMAgrawalaPKKhanGA. 2015. Extracellular RNA facilitates hypoxia-induced leukocyte adhesion and infiltration in the lung through TLR3-IFN-γ-STAT1 signaling pathway. Eur J Immunol45(11):3158–73.
9.
BoehmeAKLunaJKulickERKamelHElkindMSV. 2018. Influenza-like illness as a trigger for ischemic stroke. Ann Clin Transl Neurol5(4):456–63.
10.
BohmwaldKGalvezNMSRiosMKalergisAM. 2018. Neurologic alterations due to respiratory virus infections. Front Cell Neurosci12:386.
11.
BoschBJvan der ZeeRde HaanCARottierPJ. 2003. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol77(16):8801–11.
12.
BoucherADesforgesMDuquettePTalbotPJ. 2007. Long-term human coronavirus-myelin cross-reactive T-cell clones derived from multiple sclerosis patients. Clin Immunol123(3):258–67.
13.
CamdessancheJPMorelJPozzettoBPaulSTholanceYBotelho-NeversE. 2020. COVID-19 may induce Guillain-Barré syndrome. Rev Neurol (Paris)176(6):516–8.
14.
CarvalhoPRSiroisPFernandesPD. 2020. The role of kallikrein-kinin and renin-angiotensin systems in COVID-19 infection. Peptides135:170428.
15.
CavassaniKAIshiiMWenHSchallerMALincolnPMLukacsNW others. 2008. TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med205(11):2609–21.
16.
ChanJFWLauSKPToKKWChengVCCWooPCYYueKY. 2015. Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev28(2):465–522.
17.
ChanJFWYipCCToKKTangTHWongSCLeungKH others. 2020. Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated in vitro and with clinical specimens. J Clin Microbiol58(5):e00310-20.
18.
ChenNZhouMDongXQuJGongFHanY others. 2020a. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet395(10223):507–13.
19.
ChenYGuoYPanYZhaoZJ. 2020b. Structure analysis of the receptor binding of 2019-nCoV. Biochem Biophys Res Commun525(1):135–40.
20.
ChengQYangYGaoJ. 2020. Infectivity of human coronavirus in the brain. EBioMedicine56:102799.
21.
ColomboSBuclinTDécosterdLATelentiAFurrerHLeeBL others. 2006. Orosomucoid (α1-acid glycoprotein) plasma concentration and genetic variants: effects on human immunodeficiency virus protease inhibitor clearance and cellular accumulation. Clin Pharmacol Ther80(4):307–18.
22.
ColomboSBuclinTDécosterdLATelentiAFurrerHLeeBL others, and Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. 2020. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol5(4):536–44.
23.
CoutardBValleCde LamballerieXCanardBSeidahNGDecrolyE. 2020. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res176:104742.
24.
CuiSChenSLiXLiuSWangF. 2020. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost18(6):1421–4.
25.
DekoskySTKochanekPMValadkaABClarkRSBChouSHYAuAK others. 2020. Blood biomarkers for detection of brain injury in COVID-19 patients. J Neurotrauma. Epub Nov 11. doi:10.1089/neu.2020.7332
26.
DeleidiMIsacsonO. 2012. Viral and inflammatory triggers of neurodegenerative diseases. Sci Transl Med4(121):121ps3.
27.
DesforgesMLe CoupanecABrisonEMeessen-PinardMTalbotPJ. 2014. Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans. Adv Exp Med Biol807:75–96.
28.
DiaoBWangCWangRFengZTanYWangH others. 2020. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. medRxiv:2020.03.04.20031120.
29.
DinkinMGaoVKahanJBobkerSSimonettoMWechslerP others. 2020. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology95(5):221–3.
30.
DivaniAAAndalibSDi NapoliMLattanziSHussainMSBillerJ others. 2020. Coronavirus disease 2019 and stroke: clinical manifestations and pathophysiological insights. J Stroke Cerebrovasc Dis29(8):104941.
31.
DonoghueMHsiehFBaronasEGodboutKGosselinMStaglianoN others. 2000. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res87(5):E1–9.
32.
DubeMLe CoupanecAWongAHMRiniJMDesforgesMTalbotPJ. 2018. Axonal transport enables neuron-to-neuron propagation of human coronavirus OC43. J Virol92(17):e00404-18.
33.
EliezerMHautefortCHamelA-LVerillaudBHermanPHoudartE others. 2020. Sudden and complete olfactory loss function as a possible symptom of COVID-19. JAMA Otolaryngol Head Neck Surg146(7):674–5.
34.
ElkonKCasaliP. 2008. Nature and functions of autoantibodies. Nat Clin Pract Rheumatol4(9):491–8.
35.
EnglishJDYavagalDRGuptaRJanardhanVZaidatOOXavierAR others. 2016. Mechanical thrombectomy-ready comprehensive stroke center requirements and endovascular stroke systems of care: recommendations from the Endovascular Stroke Standards Committee of the Society of Vascular and Interventional Neurology (SVIN). Interv Neurol4(3–4):138–50.
FehrARPerlmanS. 2015. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol1282:1–23.
40.
FengYLingYBaiTXieYHuangJLiJ others. 2020. COVID-19 with different severity: a multi-center study of clinical features. Am J Respir Crit Care Med201(11):1380–8.
FuchsTABrillADuerschmiedDSchatzbergDMonestierMMyersDDJr others. 2010. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A107(36):15880–5.
43.
GregoryADHogueLAFerkolTWLinkDC. 2007. Regulation of systemic and local neutrophil responses by G-CSF during pulmonary Pseudomonas aeruginosa infection. Blood109(8):3235–43.
44.
GrobeJLMeccaAPLingisMShenoyVBoltonTAMachadoJM others. 2007. Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7). Am J Physiol Heart Circ Physiol292(2):H736–42.
45.
Gutiérrez-OrtizCMéndez-GuerreroARodrigo-ReySSan Pedro-MurilloEBermejo-GuerreroLGordo-MañasR others. 2020. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology95(5):e601–5.
HallerOKochsGWeberF. 2006. The interferon response circuit: induction and suppression by pathogenic viruses. Virology344(1):119–30.
48.
HammingITimensWBulthuisMLLelyATNavisGvan GoorH. 2004. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol203(2):631–7.
49.
HanHYangLLiuRLiuFWuKLLiJ others. 2020. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med58(7):1116–20.
HelmsJKremerSMerdjiHClere-JehlRSchenckMKummerlenC others. 2020. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med382(23):2268–70.
52.
HertzogPJO’NeillLAHamiltonJA. 2003. The interferon in TLR signaling: more than just antiviral. Trends Immunol24(10):534–9.
53.
HuangCWangYLiXRenLZhaoJHuY others. 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet395(10223):497–506.
54.
HwaKYLinWMHouYIYehTM. 2008. Peptide mimicrying between SARS coronavirus spike protein and human proteins reacts with SARS patient serum. J Biomed Biotechnol2008:326464.
55.
JacomyHTalbotPJ. 2003. Vacuolating encephalitis in mice infected by human coronavirus OC43. Virology315(1):20–33.
56.
JangHBoltzDSturm-RamirezKShepherdKRJiaoYWebsterR others. 2009. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc Natl Acad Sci U S A106(33):14063–8.
KaurCLingEA. 2017. The circumventricular organs. Histol Histopathol32(9):879–92.
59.
LaingPKnightJGHillJMHarrisAGOxfordJSWebsterRG others. 1989. Influenza viruses induce autoantibodies to a brain-specific 37-kDa protein in rabbit. Proc Natl Acad Sci U S A86(6):1998–2002.
60.
LamMHWingYKYuMWLeungCMMaRCKongAP others. 2009. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med169(22):2142–7.
61.
LazzeriERomagnanP. 2005. CXCR3-binding chemokines: novel multifunctional therapeutic targets. Current Drug Targets Immune, Endocr Metabol Disord5(1):109–18.
62.
LechienJRChiesa-EstombaCMDe SiatiDRHoroiMLe BonSDRodriguezA others. 2020. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol277(8):2251–61.
63.
LedfordH. 2020. Coronavirus breakthrough: dexamethasone is first drug shown to save lives. Nature582(7813):469.
64.
LeePIHsuehPR. 2020. Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV. J Microbiol Immunol Infect53(3):365–7.
65.
LetkoMMarziAMunsterV. 2020. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol5(4):562–9.
66.
LiYFuLGonzalesDMLaviE. 2004. Coronavirus neurovirulence correlates with the ability of the virus to induce proinflammatory cytokine signals from astrocytes and microglia. J Virol78(7):3398–406.
67.
LiYLiMWangMZhouYChangJXianY others. 2020a. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol5(3):279–84.
68.
LiYCBaiWZHashikawaT. 2020b. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol92(6):552–5.
69.
LiYCBaiWZHiranoNHayashidaTTaniguchiTSugitaY others. 2013. Neurotropic virus tracing suggests a membranous-coating-mediated mechanism for transsynaptic communication. J Comp Neurol521(1):203–12.
70.
LiuMTArmstrongDHamiltonTALaneTE. 2001. Expression of Mig (monokine induced by interferon-gamma) is important in T lymphocyte recruitment and host defense following viral infection of the central nervous system. J Immunol166(3):1790–5.
71.
LuGWangQGaoGF. 2015. Bat-to-human: spike features determining ‘host jump’ of coronaviruses SARS-CoV, MERS-CoV, and beyond. Trends Microbiol23(8):468–78.
72.
LuRZhaoXLiJNiuPYangBWuH others. 2020. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet395(10224):565–74.
73.
MaoLJinHWangMHuYChenSHeQ others. 2020a. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol77(6):683–90.
74.
MaoLWangMChenSHeQChangJHongC others. 2020b. Neurological manifestations of hospitalized patients with covid-19 in Wuhan, China: a retrospective case series study. medRxiv:2020.02.22.20026500.
75.
McCallSVilenskyJAGilmanSTaubenbergerJK. 2008. The relationship between encephalitis lethargica and influenza: a critical analysis. J Neurovirol14(3):177–85.
76.
MichalicovaABhideKBhideMKovacA. 2017. How viruses infiltrate the central nervous system. Acta Virol61(4):393–400.
MooreHBBarrettCDMooreEEMcIntyreRCMoorePKTalmorDS others. 2020. Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome?J Trauma Acute Care Surg88(6):713–4.
79.
MorassiMBagattoDCobelliMD’AgostiniSGigliGLBnàC others. 2020. Stroke in patients with SARS-CoV-2 infection: case series. J Neurol267(8):2185–92.
80.
MoriguchiTHariiNGotoJHaradaDSugawaraHTakaminoJ others. 2020. A first case of meningitis/encephalitis associated with SARS-coronavirus-2. Int J Infect Dis94:55–8.
81.
NehmeAZoueinFAZayeriZDZibaraK. 2019. An update on the tissue renin angiotensin system and its role in physiology and pathology. J Cardiovasc Dev Dis6(2):14.
82.
NetlandJMeyerholzDKMooreSCassellMPerlmanS. 2008. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol82(15):7264–75.
83.
OkabayashiTKariwaHYokotaSIkiSIndohTYokosawaN others. 2006. Cytokine regulation in SARS coronavirus infection compared to other respiratory virus infections. J Med Virol78(4):417–24.
84.
OldstoneMB. 1998. Molecular mimicry and immune-mediated diseases. FASEB J12(13):1255–65.
85.
O’NeillLABowieAG. 2007. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol7(5):353–64.
86.
OxleyTJMoccoJMajidiSKellnerCPShoirahHSinghIP others. 2020. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med382(20):e60.
Paniz-MondolfiABryceCGrimesZGordonREReidyJLednickyJ others. 2020. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol92(7):699–702.
89.
PaulMPoyan MehrAKreutzR. 2006. Physiology of local renin-angiotensin systems. Physiol Rev86(3):747–803.
RiewaldMPetrovanRJDonnerARufW. 2003. Activated protein C signals through the thrombin receptor PAR1 in endothelial cells. J Endotoxin Res9(5):317–21.
92.
Rodrigues PrestesTRRochaNPMirandaASTeixeiraALSimoes-E-SilvaAC. 2017. The anti-inflammatory potential of ACE2/angiotensin-(1-7)/Mas receptor axis: evidence from basic and clinical research. Curr Drug Targets18(11):1301–13.
93.
RogersJPChesneyEOliverDPollakTAMcGuirePFusar-PoliP others. 2020. Psychiatric and neuropsychiatric syndromes and COVID-19—Authors’ reply. Lancet Psychiatry7(8):664–5.
94.
RothanHAByrareddySN. 2020. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun109:102433.
95.
RotheCSchunkMSothmannPBretzelGFroeschlGWallrauchC others. 2020. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med382(10):970–1.
Sharifi-RazaviAKarimiNRouhaniN. 2020. COVID-19 and intracerebral haemorrhage: causative or coincidental?New Microbes New Infect35:100669.
98.
Simões e SilvaACSilveiraKDFerreiraAJTeixeiraMM. 2013. ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis. Br J Pharmacol169(3):477–92.
99.
SisoSJeffreyMGonzalezL. 2010. Sensory circumventricular organs in health and disease. Acta Neuropathol120(6):689–705.
100.
SohalSMossammatM. 2020. COVID-19 presenting with seizures. IDCases20:e00782.
101.
SolowiejJThomsonJARyanKLuoCHeMLouJ others. 2008. Steady-state and pre-steady-state kinetic evaluation of severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro cysteine protease: development of an ion-pair model for catalysis. Biochemistry47(8):2617–30.
StewartJNMounirSTalbotPJ. 1992. Human coronavirus gene expression in the brains of multiple sclerosis patients. Virology191(1):502–5.
104.
TangNLiDWangXSunZ. 2020. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost18(4):844–7.
105.
TikellisCThomasMC. 2012. Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. Int J Pept2012:256294.
106.
ToscanoGPalmeriniFRavagliaSRuizLInvernizziPCuzzoniMG others. 2020. Guillain-Barre syndrome associated with SARS-CoV-2. N Engl J Med382(26):2574–6.
107.
ValderramaEVHumbertKLordAFronteraJYaghiS. 2020. Severe acute respiratory syndrome coronavirus 2 infection and ischemic stroke. Stroke51(7):e124–7.
108.
VaratharajAThomasNEllulMADaviesNWSPollakTATenorioEL others. 2020. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry7(10):875–82.
109.
VellingiriBJayaramayyaKIyerMNarayanasamyAGovindasamyVGiridharanB others. 2020. COVID-19: a promising cure for the global panic. Sci Total Environ725:138277.
110.
VindegaardNBenrosME. 2020. COVID-19 pandemic and mental health consequences: systematic review of the current evidence. Brain Behav Immun89:531–42.
111.
WallsACTortoriciMASnijderJXiongXBoschBJReyFA others. 2017. Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion. Proc Natl Acad Sci U S A114(42):11157–62.
112.
WangDLuJ. 2004. Glycan arrays lead to the discovery of autoimmunogenic activity of SARS-CoV. Physiol Genomics18(2):245–8.
113.
WangWXuYGaoRLuRHanKWuG others. 2020a. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA323(18):1843–4.
114.
WangXXuWHuGXiaSSunZLiuZ others. 2020b. SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion. Cell Mol Immunol17(8):894.
115.
WeissSRNavas-MartinS. 2005. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev69(4):635–64.
116.
WongCKLamCWWuAKIpWKLeeNLChanIH others. 2004. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol136(1):95–103.
117.
WongPFCraikSNewmanPMakanASrinivasanKCrawfordE others. 2020. Lessons of the month 1: a case of rhombencephalitis as a rare complication of acute COVID-19 infection. Clin Med (Lond) 20(3):293–4.
118.
WongRAlan WuKFTLeeNLamCWKC K WongPKSCNgMHL others. 2003. Haematological changes in patients with severe acute respiratory syndrome. BMJ326:1358–62.
WrightJWHardingJW. 2013. The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases. Pflugers Arch465(1):133–51.
123.
WuYXuXChenZDuanJHashimotoKYangL others. 2020. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun87:18–22.
124.
XiangY-TYangYLiWZhangLZhangQCheungT others. 2020. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. Lancet Psychiatry7(3):228–9.
XuJZhongSLiuJLiLLiYWuX others. 2015. Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine Mig in pathogenesis. Clin Infect Dis41(8):1089–96.
127.
YangYHHuangYHChuangYHPengCMWangLCLinYT others. 2005. Autoantibodies against human epithelial cells and endothelial cells after severe acute respiratory syndrome (SARS)-associated coronavirus infection. J Med Virol77(1):1–7.
ZhangBZChuHHanSShuaiHDengJHuYF others. 2020a. SARS-CoV-2 infects human neural progenitor cells and brain organoids. 30(10):928–31.
130.
ZhangHPenningerJMLiYZhongNSlutskyAS. 2020b. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med46(4):586–90.
131.
ZhangTWuQZhangZ. 2020c. Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak. Curr Biol30(7):1346–1351.e2.
132.
ZhaoHShenDZhouHLiuJChenS. 2020. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?Lancet Neurol19(5):383–4.
133.
ZhouFYuTDuRFanGLiuYLiuZ others. 2020a. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet395(10229):1054–62.
134.
ZhouLMiranda-SaksenaMSaksenaNK. 2013. Viruses and neurodegeneration. Virol J10:172.
135.
ZhouPYangX-LWangX-GHuBZhangLZhangW others. 2020b. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature579(7798):270–3.
136.
ZhuNZhangDWangWLiXYangBSongJ others. 2020. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med382(8):727–33.
137.
ZuoYYalavarthiSShiHGockmanKZuoMMadisonJA others. 2020. Neutrophil extracellular traps (NETs) as markers of disease severity in COVID-19. medRxiv:2020.04.09.20059626.
